ADC Therapeutics · 1 week ago
Associate Director, Regional Marketing (Mid-Atlantic Region)
ADC Therapeutics is a commercial, global leader in the field of antibody-drug conjugates dedicated to transforming cancer treatment. The Associate Director, Regional Marketing will lead regional marketing efforts, engage with key thought leaders, and collaborate with cross-functional teams to enhance marketing strategies in the Mid-Atlantic region.
Responsibilities
Lead and execute regional marketing plans
Work with the Agency of Record (AOR) and home office to develop and to execute regional marketing plans including asset deployment, media execution (geo-targeting), and congress planning
Identify, monitor, and report key performance metrics for the region
Align with cross functional matrix team on local account planning (Associate Director, Strategic Accounts, Hematology Therapeutic Specialists)
Identify local and regional HCPs to participate in key commercial projects including webcasts, videos, promotional materials, and training opportunities
Identify and develop regional and local thought leaders
Identifies, develops, and engages with local and regional KOLs across, Hematology/Oncology and especially within the lymphoma expert community in the region
Works with Agency of Record and brand team to map regional TL influence and support regional account plan development and execution
Develop and execute regional advisory boards and third-party program plans
Identify and develop local and regional HCPs to participate in the ADC Therapeutics Speaker Bureau for ZYNLONTA and disease state programs
Conference attendance and Executive Engagements
Attend key regional and national conferences to meet with TLs and other key customers and gather competitive insights
Work with field leadership to coordinate and align on appropriate company presence onsite
Arrange meetings with TLs and company leadership
Work with Digital marketing on geotargeting and advertising opportunities
Insight gathering for HQ and field leadership
Collaborates and communicates with headquarters, the region’s field commercial and medical teams, and Clinical Development to maintain KOL coordination and manage appropriate distinction of roles and boundaries among the expertise areas
Monitors Lymphoma Treater landscape to understand community beliefs about ZYNLONTA and relevant external (competitor) events and data
Coordinate and execute local Patient Advocacy events
Work with Patient marketing, corporate communications, and sales to effectively support advocacy meetings and events especially where appropriate TL engagement is possible
Agency Management
Work with Regional Marketing Lead to manage agency partnerships and ensure appropriate budget allocation
Other duties, as assigned
Qualification
Required
Bachelor's Degree required
5 or more years' work experience required in the pharmaceutical or biotech industry, specifically in hematology and oncology and experience in academic settings important
Product launch experience in hematology or oncology
At least 2 years' previous direct experience with hematology thought leaders (physician and nurse) with demonstrated access to academic and key institutions
2 years of experience in marketing/agency or another related in-house commercial role
Exceptional presentation, interpersonal, cross-functional collaboration, and strategic thinking skills
Comfort understanding and explaining complex clinical data and disease state information with internal stakeholders and external customers
Proven track record for consistently meeting or exceeding qualitative and /or quantitative goals
Experience developing strategy and executing tactics with oversight or direct management of budget
40-50% domestic travel required
Preferred
Health care certification/qualification (e.g. RN, RPh, other)
2+ years previous field sales or market access leadership experience in the pharmaceutical or biotech industry
Proven and thorough knowledge of commercial issues associated with highly competitive hematology / oncology therapeutic areas
Company
ADC Therapeutics
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Funding
Current Stage
Public CompanyTotal Funding
$1.02BKey Investors
TCG CrossoverRedmile GroupDeerfield
2025-10-13Post Ipo Equity· $60M
2025-06-12Post Ipo Equity· $100M
2024-05-06Post Ipo Equity· $105M
Recent News
Canada NewsWire
2025-12-19
2025-12-11
Company data provided by crunchbase